Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BCPC vs CTVA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BCPC
Balchem Corporation

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$5.17B
5Y Perf.+60.3%
CTVA
Corteva, Inc.

Agricultural Inputs

Basic MaterialsNYSE • US
Market Cap$54.89B
5Y Perf.+199.4%

BCPC vs CTVA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BCPC logoBCPC
CTVA logoCTVA
IndustryChemicals - SpecialtyAgricultural Inputs
Market Cap$5.17B$54.89B
Revenue (TTM)$1.06B$17.89B
Net Income (TTM)$158M$1.16B
Gross Margin36.3%33.5%
Operating Margin21.0%13.8%
Forward P/E31.2x22.3x
Total Debt$192M$2.58B
Cash & Equiv.$75M$4.52B

BCPC vs CTVALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BCPC
CTVA
StockMay 20May 26Return
Balchem Corporation (BCPC)100160.3+60.3%
Corteva, Inc. (CTVA)100299.4+199.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: BCPC vs CTVA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BCPC leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Corteva, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
BCPC
Balchem Corporation
The Growth Play

BCPC carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
  • 8.8% revenue growth vs CTVA's 2.9%
  • 15.0% margin vs CTVA's 6.5%
Best for: growth exposure
CTVA
Corteva, Inc.
The Income Pick

CTVA is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 5 yrs, beta 0.29, yield 0.9%
  • 195.9% 10Y total return vs BCPC's 162.8%
  • Lower volatility, beta 0.29, Low D/E 10.6%, current ratio 1.43x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthBCPC logoBCPC8.8% revenue growth vs CTVA's 2.9%
ValueCTVA logoCTVALower P/E (22.3x vs 31.2x), PEG 1.87 vs 2.44
Quality / MarginsBCPC logoBCPC15.0% margin vs CTVA's 6.5%
Stability / SafetyCTVA logoCTVABeta 0.29 vs BCPC's 0.33, lower leverage
DividendsBCPC logoBCPC0.5% yield, 11-year raise streak, vs CTVA's 0.9%
Momentum (1Y)CTVA logoCTVA+32.1% vs BCPC's -0.8%
Efficiency (ROA)BCPC logoBCPC9.4% ROA vs CTVA's 2.7%, ROIC 12.2% vs 8.5%

BCPC vs CTVA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BCPCBalchem Corporation
FY 2025
Product Sales
99.8%$1.0B
Royalty
0.2%$2M
CTVACorteva, Inc.
FY 2025
Seed
39.7%$9.9B
Crop Protection
30.1%$7.5B
Herbicides
15.0%$3.7B
Insecticides
6.7%$1.7B
Fungicides
4.6%$1.1B
Biologicals
2.1%$519M
Other
1.8%$445M

BCPC vs CTVA — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCTVALAGGINGBCPC

Income & Cash Flow (Last 12 Months)

BCPC leads this category, winning 4 of 6 comparable metrics.

CTVA is the larger business by revenue, generating $17.9B annually — 16.9x BCPC's $1.1B. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to CTVA's 6.5%.

MetricBCPC logoBCPCBalchem Corporati…CTVA logoCTVACorteva, Inc.
RevenueTrailing 12 months$1.1B$17.9B
EBITDAEarnings before interest/tax$267M$3.4B
Net IncomeAfter-tax profit$158M$1.2B
Free Cash FlowCash after capex$182M$2.1B
Gross MarginGross profit ÷ Revenue+36.3%+33.5%
Operating MarginEBIT ÷ Revenue+21.0%+13.8%
Net MarginNet income ÷ Revenue+15.0%+6.5%
FCF MarginFCF ÷ Revenue+17.2%+11.5%
Rev. Growth (YoY)Latest quarter vs prior year+8.1%+11.0%
EPS Growth (YoY)Latest quarter vs prior year+10.6%+12.6%
BCPC leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CTVA leads this category, winning 5 of 7 comparable metrics.

At 34.0x trailing earnings, BCPC trades at a 34% valuation discount to CTVA's 51.1x P/E. Adjusting for growth (PEG ratio), BCPC offers better value at 2.65x vs CTVA's 4.28x — a lower PEG means you pay less per unit of expected earnings growth.

MetricBCPC logoBCPCBalchem Corporati…CTVA logoCTVACorteva, Inc.
Market CapShares × price$5.2B$54.9B
Enterprise ValueMkt cap + debt − cash$5.3B$52.9B
Trailing P/EPrice ÷ TTM EPS33.97x51.10x
Forward P/EPrice ÷ next-FY EPS est.31.23x22.30x
PEG RatioP/E ÷ EPS growth rate2.65x4.28x
EV / EBITDAEnterprise value multiple20.06x13.85x
Price / SalesMarket cap ÷ Revenue4.98x3.15x
Price / BookPrice ÷ Book value/share4.18x2.26x
Price / FCFMarket cap ÷ FCF29.86x19.50x
CTVA leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

BCPC leads this category, winning 7 of 9 comparable metrics.

BCPC delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $5 for CTVA. CTVA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to BCPC's 0.15x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs CTVA's 6/9, reflecting strong financial health.

MetricBCPC logoBCPCBalchem Corporati…CTVA logoCTVACorteva, Inc.
ROE (TTM)Return on equity+12.4%+4.6%
ROA (TTM)Return on assets+9.4%+2.7%
ROICReturn on invested capital+12.2%+8.5%
ROCEReturn on capital employed+14.8%+8.6%
Piotroski ScoreFundamental quality 0–996
Debt / EquityFinancial leverage0.15x0.11x
Net DebtTotal debt minus cash$117M-$1.9B
Cash & Equiv.Liquid assets$75M$4.5B
Total DebtShort + long-term debt$192M$2.6B
Interest CoverageEBIT ÷ Interest expense15.23x5.82x
BCPC leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CTVA leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CTVA five years ago would be worth $17,540 today (with dividends reinvested), compared to $12,441 for BCPC. Over the past 12 months, CTVA leads with a +32.1% total return vs BCPC's -0.8%. The 3-year compound annual growth rate (CAGR) favors CTVA at 13.3% vs BCPC's 8.6% — a key indicator of consistent wealth creation.

MetricBCPC logoBCPCBalchem Corporati…CTVA logoCTVACorteva, Inc.
YTD ReturnYear-to-date+4.8%+20.9%
1-Year ReturnPast 12 months-0.8%+32.1%
3-Year ReturnCumulative with dividends+28.0%+45.5%
5-Year ReturnCumulative with dividends+24.4%+75.4%
10-Year ReturnCumulative with dividends+162.8%+195.9%
CAGR (3Y)Annualised 3-year return+8.6%+13.3%
CTVA leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CTVA leads this category, winning 2 of 2 comparable metrics.

CTVA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than BCPC's 0.33 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CTVA currently trades 95.5% from its 52-week high vs BCPC's 87.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBCPC logoBCPCBalchem Corporati…CTVA logoCTVACorteva, Inc.
Beta (5Y)Sensitivity to S&P 5000.33x0.29x
52-Week HighHighest price in past year$183.90$85.63
52-Week LowLowest price in past year$139.17$60.54
% of 52W HighCurrent price vs 52-week peak+87.8%+95.5%
RSI (14)Momentum oscillator 0–10032.364.4
Avg Volume (50D)Average daily shares traded189K3.4M
CTVA leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — BCPC and CTVA each lead in 1 of 2 comparable metrics.

Wall Street rates BCPC as "Buy" and CTVA as "Buy". Consensus price targets imply 7.8% upside for CTVA (target: $88) vs 0.4% for BCPC (target: $162). For income investors, CTVA offers the higher dividend yield at 0.86% vs BCPC's 0.54%.

MetricBCPC logoBCPCBalchem Corporati…CTVA logoCTVACorteva, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$162.00$88.17
# AnalystsCovering analysts1037
Dividend YieldAnnual dividend ÷ price+0.5%+0.9%
Dividend StreakConsecutive years of raises115
Dividend / ShareAnnual DPS$0.87$0.71
Buyback YieldShare repurchases ÷ mkt cap+2.1%+2.0%
Evenly matched — BCPC and CTVA each lead in 1 of 2 comparable metrics.
Key Takeaway

CTVA leads in 3 of 6 categories (Valuation Metrics, Total Returns). BCPC leads in 2 (Income & Cash Flow, Profitability & Efficiency). 1 tied.

Best OverallCorteva, Inc. (CTVA)Leads 3 of 6 categories
Loading custom metrics...

BCPC vs CTVA: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is BCPC or CTVA a better buy right now?

For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.

8% revenue growth year-over-year, versus 2. 9% for Corteva, Inc. (CTVA). Balchem Corporation (BCPC) offers the better valuation at 34. 0x trailing P/E (31. 2x forward), making it the more compelling value choice. Analysts rate Balchem Corporation (BCPC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BCPC or CTVA?

On trailing P/E, Balchem Corporation (BCPC) is the cheapest at 34.

0x versus Corteva, Inc. at 51. 1x. On forward P/E, Corteva, Inc. is actually cheaper at 22. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Corteva, Inc. wins at 1. 87x versus Balchem Corporation's 2. 44x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — BCPC or CTVA?

Over the past 5 years, Corteva, Inc.

(CTVA) delivered a total return of +75. 4%, compared to +24. 4% for Balchem Corporation (BCPC). Over 10 years, the gap is even starker: CTVA returned +195. 9% versus BCPC's +162. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BCPC or CTVA?

By beta (market sensitivity over 5 years), Corteva, Inc.

(CTVA) is the lower-risk stock at 0. 29β versus Balchem Corporation's 0. 33β — meaning BCPC is approximately 12% more volatile than CTVA relative to the S&P 500. On balance sheet safety, Corteva, Inc. (CTVA) carries a lower debt/equity ratio of 11% versus 15% for Balchem Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — BCPC or CTVA?

By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.

8% versus 2. 9% for Corteva, Inc. (CTVA). On earnings-per-share growth, the picture is similar: Corteva, Inc. grew EPS 23. 1% year-over-year, compared to 20. 9% for Balchem Corporation. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BCPC or CTVA?

Balchem Corporation (BCPC) is the more profitable company, earning 14.

9% net margin versus 6. 3% for Corteva, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus 15. 1% for CTVA. At the gross margin level — before operating expenses — CTVA leads at 43. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BCPC or CTVA more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Corteva, Inc. (CTVA) is the more undervalued stock at a PEG of 1. 87x versus Balchem Corporation's 2. 44x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Corteva, Inc. (CTVA) trades at 22. 3x forward P/E versus 31. 2x for Balchem Corporation — 8. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTVA: 7. 8% to $88. 17.

08

Which pays a better dividend — BCPC or CTVA?

All stocks in this comparison pay dividends.

Corteva, Inc. (CTVA) offers the highest yield at 0. 9%, versus 0. 5% for Balchem Corporation (BCPC).

09

Is BCPC or CTVA better for a retirement portfolio?

For long-horizon retirement investors, Corteva, Inc.

(CTVA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 9% yield, +195. 9% 10Y return). Both have compounded well over 10 years (CTVA: +195. 9%, BCPC: +162. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BCPC and CTVA?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BCPC

Stable Dividend Mega-Cap

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Stocks Like

CTVA

Stable Dividend Mega-Cap

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BCPC and CTVA on the metrics below

Revenue Growth>
%
(BCPC: 8.1% · CTVA: 11.0%)
Net Margin>
%
(BCPC: 15.0% · CTVA: 6.5%)
P/E Ratio<
x
(BCPC: 34.0x · CTVA: 51.1x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.